Published 9 days ago • loading... • Updated 9 days ago

Corbus reports first Western data for closely tracked ADC cancer drug

Summary by STAT

In a study conducted in the U.S. and the U.K., the Corbus drug, called CRB-701 showed an overall response rate of 27% from 26 evaluable patients.

1 Articles

All

Left

Center

Right

In a study conducted in the U.S. and the U.K., the Corbus drug, called CRB-701 showed an overall response rate of 27% from 26 evaluable patients.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated9 days agoBias Distribution

100% Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States 9 days ago on Friday, February 14, 2025.

Sources are mostly out of (0)